Type-2 diabetes (T2DM) worsens cognitive decline and impairs insulin signaling in Alzheimer’s disease (AD), with both conditions involving disrupted glucose metabolism-T2DM through chronic hyperglycemia and AD through impaired neuronal glucose uptake. This evidence concerns the gene INS and early-onset autosomal dominant Alzheimer disease.